Table 2.

Patient satisfaction 17 with TRT is partially due to factors that are unique to the chosen 18 modality.

Reasons for Preference	Gel (n=108)	Injection (n=194)	Pellet (n=64)
Cost	21.3% (n=23) *	34.5% (n=67) $,#	18.8% (n=12) *
Ease of use	42.6% (n=46) #	43.8% (n=85) #	64.1% (n=41) *,$
Ability to raise testosterone levels	26.9% (n=29) *	42.8% (n=83) $	34.4% (n=22)
Improvement in symptoms	21.3% (n=23) *	41.2% (n=80) $	32.8% (n=21)
Doctor recommendation	65.7% (n=71) #,*	37.1% (n=72) $	31.3% (n=20) $
Concern for transference	0.1% (n=1) *,#	28.4% (n=55) $	37.5% (n=24) $
Convenience	19.4% (n=21) #	26.3% (n=51) #	57.8% (n=37) *,$

A significance of p<0.05 is shown between groups and are depicted as:

^*vs. injection,

^$vs. Gel,

^#vs. Pellets.